Clinical Trial Update: Injection Regimen Trial of PEG-rhG-CSF During Breast Cancer Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial update for an injection regimen of PEG-rhG-CSF during chemotherapy in breast cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• PEG-rhG-CSF (pegylated recombinant human granulocyte colony-stimulating factor)

Snippet

Sponsor: The First Affiliated Hospital with Nanjing Medical University | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED